Michael J. Grant MDClinical Fellow, Hematology and Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut
Dr. Michael Grant is a fellow at Yale Cancer Center associated with the Yale University School of Medicine. Dr. Grant’s current research interests include EGFR mutation positive lung cancer, and immunotherapy approaches for the treatment of lung cancer. His work is in both translational research and clinical investigation.
Dr. Grant obtained his undergraduate degree with a dual major in Mathematics and Biology from Dickinson College in Carlisle, Pennsylvania. He then graduated from the Albert Einstein School of Medicine, where he obtained his MD. Dr. Grant then completed residency training in Internal Medicine at Duke University Hospital, Duke University School of Medicine. He is board certified in internal medicine.
Recent Contributions to PracticeUpdate:
- Stage IIIB Lung Adenocarcinoma With EGFR L858R Mutation
- Meeting Unmet Needs in Precision Therapy for NSCLC: Promising Therapies From WCLC 2020—Introduction
- Meeting Unmet Needs in Precision Therapy for NSCLC: Promising Therapies From WCLC 2020—Sotorasib
- Meeting Unmet Needs in Precision Therapy for NSCLC: Promising Therapies From WCLC 2020—Amivantamab
- Optimal First-Line Precision Therapy for Adenocarcinoma